RMEIX Performance — Aspiriant Risk-Managed Equity Allocation Fund
Data updated: 2026-08-25
RMEIX returned +6.76% year to date and +16.19% over one year to Jun 2026. Annualised returns are +15.06% over 3 years and +8.72% over 5 years. The fund beat its Hedged category average: $100 invested three years ago grew to $152, against $134 for the category, and to $116 over one year, against $105. Volatility over the past three years was 8.97% a year. In the 12 months to Jun 2026 the fund lost a net $6.5M, and assets reached $1.41B. Returns are those of sibling share class RMEAX; this class's own returns are not reported in filings.
RMEIX Growth of $100
What $100 invested in Aspiriant Risk-Managed Equity Allocation Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Hedged category average over the same months.
| Period | RMEIX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $116 | $105 |
| 3 years (Jul 2023 – Jun 2026) | $152 | $134 |
| 5 years (Jul 2021 – Jun 2026) | $152 | $104 |
| Since data start (Sep 2019 – Jun 2026) | $185 | $113 |
RMEIX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +6.76% |
| 1 year | +16.19% |
| 3 years (annualised) | +15.06% |
| 5 years (annualised) | +8.72% |
RMEIX Annual Returns
Calendar-year total returns of Aspiriant Risk-Managed Equity Allocation Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +6.76% |
| 2025 | +17.65% |
| 2024 | +14.72% |
| 2023 | +16.16% |
| 2022 | −13.65% |
| 2021 | +14.78% |
| 2020 | +3.97% |
| 2019 (Sep–Dec) | +7.24% |
RMEIX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +2.1% | +0.5% | −5.9% | +7.1% | +3.1% | +0.1% | — | — | — | — | — | — |
| 2025 | +3.7% | +0.4% | −2.4% | −0.6% | +3.5% | +3.5% | −0.7% | +2.8% | +2.4% | +1.0% | +2.1% | +1.1% |
| 2024 | +1.9% | +3.3% | +2.2% | −2.1% | +2.8% | +2.4% | +1.3% | +2.8% | +1.6% | −2.1% | +2.4% | −2.3% |
| 2023 | +4.3% | −3.0% | +3.2% | +2.0% | −0.9% | +4.0% | +2.4% | −1.6% | −2.5% | −1.1% | +6.0% | +2.6% |
| 2022 | −3.2% | −3.8% | +0.5% | −4.5% | −0.1% | −4.8% | +3.2% | −3.1% | −7.3% | +5.2% | +6.7% | −2.3% |
| 2021 | −0.5% | +1.0% | +2.9% | +3.7% | +1.9% | −0.1% | +1.1% | +2.0% | −4.0% | +3.8% | −2.2% | +4.5% |
| 2020 | −1.2% | −5.2% | −11.4% | +7.1% | +1.5% | +0.8% | +4.3% | +3.3% | −2.5% | −1.7% | +6.8% | +3.8% |
| 2019 | — | — | — | — | — | — | — | — | +1.6% | +1.9% | +0.7% | +3.0% |
RMEIX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 8.97%
- 3-year Sharpe ratio: 1.18 (vs 4.5% risk-free rate)
- Best month: +7.12% (Apr 2026)
- Worst month: −5.87% (Mar 2026)
RMEIX Fund Flows
Monthly money in and out of Aspiriant Risk-Managed Equity Allocation Fund, from SEC Form N-PORT.
- 12-month net flow: −$6.5M
- 12-month gross sales (incl. reinvestments): $247.5M
- Sales ÷ redemptions: 0.97×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $8.2M | $7.4M | $719K |
| May 2026 | $11.1M | $5.9M | $5.2M |
| Apr 2026 | $6.6M | $18.6M | −$12.0M |
| Mar 2026 | $9.0M | $11.3M | −$2.3M |
| Feb 2026 | $7.6M | $7.9M | −$334K |
| Jan 2026 | $41.6M | $7.3M | $34.3M |
| Dec 2025 | $146.1M | $146.9M | −$768K |
| Nov 2025 | $1.7M | $9.1M | −$7.4M |
| Oct 2025 | $4.6M | $15.9M | −$11.3M |
| Sep 2025 | $3.5M | $6.6M | −$3.1M |
| Aug 2025 | $5.6M | $8.5M | −$2.9M |
| Jul 2025 | $2.0M | $8.6M | −$6.6M |
RMEIX Assets Under Management
Net assets of Aspiriant Risk-Managed Equity Allocation Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $1.41B |
| 2026-03-31 | $1.28B |
| 2025-12-31 | $1.30B |
| 2025-09-30 | $1.41B |
| 2025-06-30 | $1.36B |
| 2025-03-31 | $1.30B |
| 2024-12-31 | $1.28B |
| 2024-09-30 | $1.43B |
| 2024-06-30 | $1.39B |
| 2024-03-31 | $1.40B |
| 2023-12-31 | $1.41B |
| 2023-09-30 | $1.41B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.